Bristol-Myers Squibb To Acquire Celgene in a $74B Blockbuster Deal
Posted by
www.biotecnika.org
Bristol-Myers Squibb To Acquire Celgene in a $74B Blockbuster Deal In
a blockbuster deal valued at $74B, Bristol-Myers Squibb will be
acquiring Cancer drug specialists – Biotech company – Celgene, the
announcement for the same was made by the respective companies on
Thursday. Via the deal, Bristol-Myers aims at becoming the sole
powerhouse in Oncology, cardiovascular disease […]
The post Bristol-Myers Squibb To Acquire Celgene in a $74B Blockbuster
Deal appeared first on BioTecNika .
https://www.biotecnika.org/2019/01/bristol-myers-squibb-to-acquire-celgene-in-a-74b-blockbuster-deal/
Biotech News
Subscribe to:
Post Comments (Atom)
Post a Comment